Impact of accelerated ventricular tachyarrhythmias on mortality in patients with implantable cardioverter-defibrillator therapy

International Journal of Cardiology

Volumn 167, Issue 6, 2013, Pages 3006-3010

  Schukro, Christoph ^a   Leitner, Lukas ^a   Siebermair, Johannes ^a   Pezawas, Thomas ^a   Stix, Günter ^a   Kastner, Johannes ^a   Schmidinger, Herwig ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Accelerated tachyarrhythmia; Anti tachycardia pacing; Implantable cardioverter defibrillator; Shock

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; SOTALOL;

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MORTALITY; DEFIBRILLATION; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART SCINTISCANNING; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LONG QT SYNDROME 3; MAJOR CLINICAL STUDY; MALE; MONOMORPHIC VENTRICULAR TACHYCARDIA; POLYMORPHIC VENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACCELERATED TACHYARRHYTHMIA; ANTI-TACHYCARDIA PACING; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; SHOCK;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; YOUNG ADULT;

EID: 84883765649     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.09.015     Document Type: Article

References (21)

1. M.S. Wathen, M.O. Sweeney, and P.J. DeGroot Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease Circulation 104 2001 796 801
2. M.S. Wathen, P.J. DeGroot, and M.O. Sweeney Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results Circulation 110 2004 2591 2596
3. M. Chinushi, M. Tagawa, and H. Kasai Antitachycardia burst pacing for pleomorphic reentrant ventricular tachycardias associated with non-coronary artery diseases: a morphology specific programming for ventricular tachycardias Jpn Heart J 41 2000 313 324
4. O. Paz, U. Birgersdotter-Green, and C. Swerdlow Acceleration of ventricular rate following atrial antitachycardia pacing: what is the mechanism? J Cardiovasc Electrophysiol 14 2003 1382 1384
5. A. Schaumann, F. von zur Mühlen, B. Herse, B.D. Gonska, and H. Kreuzer Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: a prospective study including 200 patients Circulation 97 1998 66 74
6. R.W. Peters, X. Zhang, and M.R. Gold Clinical predictors and efficacy of antitachycardia pacing in patients with implantable cardioverter defibrillators: the importance of the patient's sex Pacing Clin Electrophysiol 24 2001 70 74
7. R.C. Klein, M.H. Raitt, and B.L. Wilkoff Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial J Cardiovasc Electrophysiol 14 2003 940 948
8. W. Schoels, D. Steinhaus, and W.B. Johnson Optimizing implantable cardioverter-defibrillator treatment of rapid ventricular tachycardia: antitachycardia pacing therapy during charging Heart Rhythm 4 2007 879 885
9. G. Sivagangabalan, S. Eshoo, V.E. Eipper, A. Thiagalingam, and P. Kovoor Discriminatory therapy for very fast ventricular tachycardia in patients with implantable cardioverter defibrillators Pacing Clin Electrophysiol 31 2008 1095 1099
10. M.M. Gulizia, L. Piraino, and M. Scherillo A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial Circ Arrhythm Electrophysiol 2 2009 146 153
11. D.P. Zipes, A.J. Camm, and M. Borggrefe ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death - executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Eur Heart J 27 2006 2099 2140
12. G. Steinbeck, U. Dorwarth, and S. Mattke Hemodynamic deterioration during ICD implant: predictors of high-risk patients Am Heart J 127 1994 1064 1067
13. M. Runsiö, A. Kallner, G. Källner, M. Rosenqvist, and L. Bergfeldt Myocardial injury after electrical therapy for cardiac arrhythmias assessed by troponin-T release Am J Cardiol 79 1997 1241 1245
14. T. Tokano, D. Bach, and J. Chang Effect of ventricular shock strength on cardiac hemodynamics J Cardiovasc Electrophysiol 9 1998 791 797
15. G. Benedini, A. Marchini, and A. Curnis Implantable defibrillation and thromboembolic events Pacing Clin Electrophysiol 18 1995 199 202
16. J.P. Daubert, W. Zareba, and D.S. Cannom Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact J Am Coll Cardiol 51 2008 1357 1365
17. J.E. Poole, G.W. Johnson, and A.S. Hellkamp Prognostic importance of defibrillator shocks in patients with heart failure N Engl J Med 359 2008 1009 1017
18. M.O. Sweeney, L. Sherfesee, P.J. DeGroot, M.S. Wathen, and B.L. Wilkoff Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients Heart Rhythm 7 2010 353 360
19. S.P. Bhavnani, J. Kluger, and C.I. Coleman The prognostic impact of shocks for clinical and induced arrhythmias on morbidity and mortality among patients with implantable cardioverter-defibrillators Heart Rhythm 7 2010 755 760
20. B.L. Wilkoff, B.D. Williamson, and R.S. Stern Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study J Am Coll Cardiol 52 2008 541 550
21. M. Gasparini, C. Menozzi, and A. Proclemer A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study Eur Heart J 30 2009 2758 2767